Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy
- PMID: 32310245
- PMCID: PMC7154312
- DOI: 10.1016/j.ijcha.2020.100512
Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy
Keywords: Cardiac magnetic resonance imaging; Cardiovascular risk; Flow gradient; Hypertrophic cardiomyopathy; Myocardial blood flow; Myocardial flow reserve; Positron emission tomography.
Comment on
-
Hypertrophic cardiomyopathy.Int J Cardiol Heart Vasc. 2020 Mar 25;27:100503. doi: 10.1016/j.ijcha.2020.100503. eCollection 2020 Apr. Int J Cardiol Heart Vasc. 2020. PMID: 32309534 Free PMC article. Review.
References
-
- Veselka J., Anavekar N.S., Charron P. Hypertrophic obstructive cardiomyopathy. Lancet. 2017;389:1253–1267. - PubMed
-
- Valenta I., Szabo Z., Mathews W.B., Abraham T.P., Abraham M.R., Schindler T.H. PET/CT imaging of cardiac angiotensin II Type 1 receptors in nonobstructive hypertrophic cardiomyopathy. JACC Cardiovasc. Imaging. 2019;12:1895–1896. - PubMed
Publication types
LinkOut - more resources
Full Text Sources